Anti-Correlated Myelin-Sensitive MRI Levels in Humans Consistent with a Subcortical to Sensorimotor Regulatory Process-Multi-Cohort Multi-Modal Evidence. — CFSMEATLAS
Anti-Correlated Myelin-Sensitive MRI Levels in Humans Consistent with a Subcortical to Sensorimotor Regulatory Process-Multi-Cohort Multi-Modal Evidence.
Barnden, Leighton, Crouch, Benjamin, Kwiatek, Richard et al. · Brain sciences · 2022 · DOI
Quick Summary
This study looked at brain scans from people with ME/CFS and healthy people to understand how the brain protects and maintains nerve fibers (myelin). Researchers found that healthy people show a balancing pattern: when one part of the brain has less myelin coverage, another part compensates by having more. The study suggests this balance may be disrupted in ME/CFS, which could contribute to symptom severity.
Why It Matters
Understanding how the brain regulates myelin in healthy people provides a benchmark for identifying where this regulation fails in ME/CFS, potentially explaining motor control symptoms and post-exertional malaise. If ME/CFS patients show disrupted myelin compensation patterns, this could guide development of therapeutic interventions targeting myelination and neurological regulation.
Observed Findings
Negative correlations between subcortical and sensorimotor myelination confirmed in healthy controls across six MRI modalities (T1wSE, T2wSE, MTC, white matter volume) with p-values ranging from 0.002 to 5×10⁻⁸.
A positive correlation was observed in T1/T2 ratio (p=0.01), suggesting different mechanistic processes across MRI parameters.
Pattern reproducibility across nine independent image-sets and three separate cohorts using different MRI equipment and protocols.
Subcortical region contains primary regulatory nuclei of the brain, positioning it as a candidate control center for this myelination balance.
Inferred Conclusions
A previously unreported regulatory interaction exists between subcortical and sensorimotor myelination in humans, whereby low myelination in one region is compensated by higher myelination in the other to maintain adequate sensorimotor function.
This regulatory mechanism is consistent with evolutionary optimization of neural signaling efficiency across different axon lengths and conduction distances.
Disruption of this anti-correlation pattern may be present in ME/CFS and could contribute to sensorimotor and regulatory dysfunction observed in the disease.
Remaining Questions
Is the healthy control anti-correlation pattern actually disrupted or altered in ME/CFS patients, and if so, does severity of disruption correlate with symptom severity?
What This Study Does Not Prove
This study demonstrates correlation, not causation—the anti-correlation pattern in healthy controls does not prove that one region actively regulates the other or that disruption of this pattern causes ME/CFS symptoms. The cross-sectional design cannot determine whether altered myelination patterns are a cause or consequence of ME/CFS, nor does the abstract clarify whether ME/CFS patients actually show disrupted anti-correlations compared to controls.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
What is the mechanistic cause of this compensatory myelination pattern—is it a primary regulatory process, developmental adaptation, or homeostatic response?
Does this myelination pattern correlate with specific ME/CFS symptoms such as post-exertional malaise, exercise intolerance, or autonomic dysfunction?
Can interventions that restore normal myelin regulation improve clinical outcomes in ME/CFS patients?